Description
A-142 MAJOR AUTOANTIBODY REACTIVITY SEROLOGY AND MINOR SYMPTOMS IN A SLE PATIENT : A CASE REPORT
- You cannot add another "Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma" to your cart. View cart
Article: A-142 MAJOR AUTOANTIBODY REACTIVITY SEROLOGY AND MINOR SYMPTOMS IN A SLE PATIENT : A CASE REPORT
€3.03
